60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $242 | $1,624 | $1,624 |
| - Cash | $2 | $2 | $0 | $0 |
| + Debt | $0 | $0 | $22 | $19 |
| Enterprise Value | $1 | $240 | $1,646 | $1,642 |
| Revenue | $1 | $0 | $0 | $1 |
| % Growth | 139.6% | 13.6% | -80.8% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 36.7% | -87.1% | -93.7% | 26.7% |
| EBITDA | -$8 | -$1 | -$2 | -$1 |
| % Margin | -1,297.6% | -562.6% | -944.9% | -87.5% |
| Net Income | -$8 | -$4 | -$6 | -$4 |
| % Margin | -1,308% | -1,485.1% | -2,769.5% | -366.4% |
| EPS Diluted | -18.55 | -0.95 | -1.07 | -0.74 |
| % Growth | -1,852.6% | 11.2% | -44.6% | – |
| Operating Cash Flow | -$6 | -$5 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$5 | -$1 | -$1 |